These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34960671)

  • 21. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
    Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
    Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
    J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
    Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
    J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
    Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport.
    Ghildyal R; Jordan B; Li D; Dagher H; Bardin PG; Gern JE; Jans DA
    J Virol; 2009 Jul; 83(14):7349-52. PubMed ID: 19403669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
    Wang HM; Liang PH
    Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
    Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
    J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.
    Watters K; Inankur B; Gardiner JC; Warrick J; Sherer NM; Yin J; Palmenberg AC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
    Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
    J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.
    Zhang XN; Song ZG; Jiang T; Shi BS; Hu YW; Yuan ZH
    World J Gastroenterol; 2010 Jan; 16(2):201-9. PubMed ID: 20066739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of potent inhibitors of the coxsackievirus 3C protease.
    Lee ES; Lee WG; Yun SH; Rho SH; Im I; Yang ST; Sellamuthu S; Lee YJ; Kwon SJ; Park OK; Jeon ES; Park WJ; Kim YC
    Biochem Biophys Res Commun; 2007 Jun; 358(1):7-11. PubMed ID: 17485072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases.
    Heinz BA; Tang J; Labus JM; Chadwell FW; Kaldor SW; Hammond M
    Antimicrob Agents Chemother; 1996 Jan; 40(1):267-70. PubMed ID: 8787922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AG-7088 Pfizer.
    Witherell G
    Curr Opin Investig Drugs; 2000 Nov; 1(3):297-302. PubMed ID: 11249711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells.
    Walker EJ; Younessi P; Fulcher AJ; McCuaig R; Thomas BJ; Bardin PG; Jans DA; Ghildyal R
    PLoS One; 2013; 8(8):e71316. PubMed ID: 23951130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhinovirus 16 2A Protease Affects Nuclear Localization of 3CD during Infection.
    Walker E; Jensen L; Croft S; Wei K; Fulcher AJ; Jans DA; Ghildyal R
    J Virol; 2016 Dec; 90(24):11032-11042. PubMed ID: 27681132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced simulations and screening to repurposing a 3C protease inhibitor against the rupintrivir-resistant human norovirus-induced gastroenteritis.
    Behmard E; Ghasemian A; Barzegari E; Farjadfar A; Kouhpayeh A; Najafipour S
    J Mol Graph Model; 2023 Jan; 118():108345. PubMed ID: 36308946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.